blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1812025

EP1812025 - STABILIZED BACTERIOPHAGE FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.07.2013
Database last updated on 07.10.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Chr. Hansen A/S
Bøge Allé 10-12
2970 Hørsholm / DK
[2009/48]
Former [2007/31]For all designated states
Cangagen Life Sciences Inc.
400, 1740 Woodroffe Ave. Suite 1
Ottawa, ON K2G 3R8 / CA
Inventor(s)01 / MURTHY, Kishore
2118 Rexton Street
Ottawa, Ontario K4A 4K8 / CA
02 / ENGELHARDT, Rainer
1712 Silver Bark Avenue
Ottawa, Ontario K1C 7A9 / CA
 [2007/31]
Representative(s)Markvardsen, Peter, et al
Chr. Hansen A/S Boge Allé 10-12 P.O. Box 407
2970 Horsholm / DK
[2010/27]
Former [2007/31]Wallace, Sheila Jane, et al
Lloyd Wise Commonwealth House, 1-19 New Oxford Street
London WC1A 1LW / GB
Application number, filing date05804032.002.11.2005
[2007/31]
WO2005CA01678
Priority number, dateUS20040624576P02.11.2004         Original published format: US 624576 P
[2007/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006047870
Date:11.05.2006
Language:EN
[2006/19]
Type: A1 Application with search report 
No.:EP1812025
Date:01.08.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2006 takes the place of the publication of the European patent application.
[2007/31]
Type: B1 Patent specification 
No.:EP1812025
Date:05.09.2012
Language:EN
[2012/36]
Search report(s)International search report - published on:CA11.05.2006
(Supplementary) European search report - dispatched on:EP12.11.2009
ClassificationIPC:A23K1/17, A23K1/18, A61K35/76
[2012/14]
CPC:
A61K35/76 (EP,US); A23K20/195 (EP,US); A23K50/10 (EP,US);
A23K50/75 (EP,US); A23K50/80 (EP,US); A61P17/02 (EP);
A61P31/04 (EP); C12N2795/00032 (EP,US); C12N2795/00051 (EP,US);
Y02A40/818 (EP) (-)
Former IPC [2007/31]A61K35/76, A61P31/04, A23K1/16, A61P17/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/31]
TitleGerman:STABILISIERTE BAKTERIOPHAGEN-FORMULIERUNGEN[2007/31]
English:STABILIZED BACTERIOPHAGE FORMULATIONS[2007/31]
French:FORMULATION A BACTERIOPHAGES STABILISEES[2007/31]
Entry into regional phase04.06.2007National basic fee paid 
04.06.2007Search fee paid 
04.06.2007Designation fee(s) paid 
04.06.2007Examination fee paid 
Examination procedure02.06.2006Request for preliminary examination filed
International Preliminary Examining Authority: CA
04.06.2007Examination requested  [2007/31]
30.07.2007Amendment by applicant (claims and/or description)
02.03.2010Despatch of a communication from the examining division (Time limit: M04)
31.05.2010Reply to a communication from the examining division
13.10.2011Despatch of a communication from the examining division (Time limit: M02)
06.12.2011Reply to a communication from the examining division
02.05.2012Communication of intention to grant the patent
26.07.2012Fee for grant paid
26.07.2012Fee for publishing/printing paid
Divisional application(s)EP12158716.6  / EP2462940
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.03.2010
Opposition(s)06.06.2013No opposition filed within time limit [2013/33]
Fees paidRenewal fee
15.11.2007Renewal fee patent year 03
12.11.2008Renewal fee patent year 04
12.11.2009Renewal fee patent year 05
12.11.2010Renewal fee patent year 06
14.11.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.11.2005
AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
IE02.11.2012
LU02.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
[2014/34]
Former [2014/27]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
IE02.11.2012
LU02.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
Former [2014/21]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
IE02.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
Former [2013/47]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
IE02.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
Former [2013/34]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
Former [2013/28]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
GR06.12.2012
IS05.01.2013
PT07.01.2013
Former [2013/23]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SE05.09.2012
SI05.09.2012
SK05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/22]AT05.09.2012
CY05.09.2012
CZ05.09.2012
EE05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
SE05.09.2012
SI05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/12]AT05.09.2012
CY05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
SE05.09.2012
SI05.09.2012
GR06.12.2012
Former [2013/11]AT05.09.2012
CY05.09.2012
FI05.09.2012
LT05.09.2012
LV05.09.2012
SI05.09.2012
GR06.12.2012
Former [2013/10]AT05.09.2012
CY05.09.2012
FI05.09.2012
LT05.09.2012
Former [2013/09]AT05.09.2012
FI05.09.2012
LT05.09.2012
Former [2013/08]AT05.09.2012
LT05.09.2012
Former [2013/07]AT05.09.2012
Documents cited:Search[XI]US2004208854  (WADDELL THOMAS E [CA], et al) [X] 2-4,7-9,11-12,19-22 * paragraphs 0004, 0009 - 0031, 0049-0051, 0054-0061,examples 2-7 * [I] 5-6,10,14-16;
 [XI]WO2004064732  (NEW HORIZONS DIAGNOSTICS CORP [US], et al) [X] 2-4,11-12,19-22 * p.78, line 5-p. 79, line 24 * [I] 5,7-10,14-15
International search[X]EP0403292  (MICROBIAL DEV LTD [GB]);
 [X]US6703040  (KATSARAVA RAMAZ [GE], et al);
 [X]WO03093462  (UNIV STRATHCLYDE [GB], et al);
 [A]WO0151066  (INTRALYTIX INC [US], et al);
 [A]WO2004045645  (BORATYNSKI JANUSZ [PL], et al)
 [X]  - JEPSON C D ET AL, "Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle.", VACCINE., (200406), vol. 22, no. 19, pages 2413 - 2419, XP004515458

DOI:   http://dx.doi.org/10.1016/j.vaccine.2003.11.065
 [X]  - SERGIENKO F E., Dry Bacterophages, Their Preparation and Use. Microbiology and Epidemiology., MEDICAL PUBLICATIONS LTD., (1945), pages 116 - 123, XP009120790
 [A]  - SULAKVELIDZE A ET AL, "Bacteriophage Therapy.", ANTIMICROB AGENTS CHEMOTHER., (200103), vol. 45, no. 3, pages 649 - 659, XP008115592

DOI:   http://dx.doi.org/10.1128/AAC.45.3.649-659.2001
 [A]  - THIEL K., "Old dogma, new tricks-21st Century phage therapy.", NATURE BIOTECHNOL., (200401), vol. 22, no. 1, pages 31 - 36, XP002404412
 [A]  - STONE R., "Bacteriophage therapy. Stalin's forgotten cure.", SCIENCE., (200210), vol. 298, no. 5594, pages 728 - 731, XP008118025

DOI:   http://dx.doi.org/10.1126/science.298.5594.728
 [A]  - BENNETT A R ET AL, "The use of bacteriophage-based systems for the separation and concentration of Salmonella.", J APPL MICROBIOL., (199708), vol. 83, no. 2, pages 259 - 265, XP001051057

DOI:   http://dx.doi.org/10.1046/j.1365-2672.1997.00257.x
 [A]  - PROUTY C C., "Storage of the Bacteriophage of the Lactic Acid Streptococci in the Desiccated State with Observations on Longevity.", APPL MICROBIOL., (1953), vol. 1, pages 250 - 251, XP008118026
by applicantUS2004208854
 WO2004064732
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.